Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Advanced Chart

Key Stats

Today's Range
$1.22
$1.26
50-Day Range
N/A
52-Week Range
$0.87
$3.07
Volume
83,337 shs
Average Volume
341,215 shs
Market Capitalization
$37.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.67
Consensus Rating
Hold

Company Overview

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
Citizens JMP healthcare analysts hold an analyst/industry conference call
Evercore ISI Keeps Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) released its quarterly earnings results on Tuesday, August, 13th. The company reported ($0.48) EPS for the quarter, beating analysts' consensus estimates of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering on Friday, March 25th 2022. The company issued 4,600,000 shares at a price of $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
4/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:ANTX
Previous Symbol
NASDAQ:ANTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.67
High Stock Price Target
$5.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+110.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-64,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.30

Miscellaneous

Free Float
23,667,000
Market Cap
$37.80 million
Optionable
Not Optionable
Beta
0.15
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:ANTX) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners